Results 71 to 80 of about 245,752 (174)

Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial*

open access: yesBritish Journal of Dermatology, 2020
Tralokinumab is a fully human monoclonal antibody that specifically neutralizes interleukin‐13, a key driver of atopic dermatitis (AD).
J. Silverberg   +11 more
semanticscholar   +1 more source

Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus.

open access: yesNew England Journal of Medicine, 2020
BACKGROUND Nemolizumab is a subcutaneously administered humanized monoclonal antibody against interleukin-31 receptor A, which is involved in pruritus and inflammation in atopic dermatitis.
K. Kabashima   +3 more
semanticscholar   +1 more source

Atopic dermatitis, cutaneous steroids and cataracts in children: two case reports

open access: yesJournal of Medical Case Reports, 2008
Introduction Atopic dermatitis is a chronic, pruritic, eczematous skin disease mediated through an immediate (type I) hypersensitivity reaction. Posterior sub-capsular cataracts are a recognised complication of atopic dermatitis in adults; however they ...
Tatham Andrew
doaj   +1 more source

Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy

open access: yesExpert review of pharmacoeconomics & outcomes research, 2020
Introduction Asthma, allergic rhinitis, atopic dermatitis, and food allergy affect approximately 20% of the global population. Few studies describe the burden of the totality of these diseases and only a handful studies provide a comprehensive overview ...
B. Dierick   +6 more
semanticscholar   +1 more source

Magnitude of atopic dermatitis and associated factors among children in northwest Ethiopia

open access: yesScientific Reports
Atopic dermatitis is a chronic inflammatory skin disease that typically begins in infancy and extends into adulthood in a small proportion of cases. Around 20% of children and 5% of adults worldwide suffer from atopic dermatitis.
Alemu Bezabih Tegegnie   +4 more
doaj   +1 more source

Isolated lip dermatitis (atopic cheilitis), successfully treated with topical tacrolimus 0.03. [PDF]

open access: yesMed Oral Patol Oral Cir Bucal, 2021
Georgakopoulou E   +3 more
europepmc   +1 more source

The Impact of Atopic Dermatitis on Sexual Function and Reproductive Desires in Women

open access: yesActa Dermato-Venereologica
Atopic dermatitis is a prevalent skin condition that affects up to 17% of adult population. It can lead to itching, pain, and other symptoms such as sleep disturbance, anxiety, and depression.
Juan-Angel Rodríguez-Pozo   +6 more
doaj   +1 more source

Comparison of Epidermal Barrier Integrity in Adults with Classic Atopic Dermatitis, Atopic Prurigo and Non-Atopic Prurigo Nodularis. [PDF]

open access: yesBiology (Basel), 2021
Fölster-Holst R   +9 more
europepmc   +1 more source

The positive effect of dupilumab on comorbid asthma in patients with atopic dermatitis

open access: yesClinical and Translational Allergy, 2023
Lotte S. Spekhorst   +11 more
doaj   +1 more source

ACTIVATED ZINC PYRITHIONE APPLICATION FOR THE ATOPIC DERMATITIS AMONG CHILDREN: MECHANISM OF ACTION, CLINICAL EFFICIENCY

open access: yesПедиатрическая фармакология, 2009
Atopic dermatitis is characterized by the chronic recurrent course and often complicated by the consecutive infection and requires an adequate and regular external treatment. This article is devoted to the overview of the key pharmacodynamic and clinical
F.I. Petrovsky, D.S. Korostovtsev
doaj   +2 more sources

Home - About - Disclaimer - Privacy